Syphilis vaccine development: Aligning vaccine design with manufacturing requirements.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 Dec 2024
Historique:
medline: 12 9 2024
pubmed: 12 9 2024
entrez: 12 9 2024
Statut: ppublish

Résumé

Syphilis, caused by

Identifiants

pubmed: 39262177
doi: 10.1080/21645515.2024.2399915
doi:

Substances chimiques

Bacterial Vaccines 0
Vaccines, Virus-Like Particle 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2399915

Auteurs

Sean Waugh (S)

Department of Biochemistry and Microbiology, University of Victoria, Victoria, Canada.

Caroline E Cameron (CE)

Department of Biochemistry and Microbiology, University of Victoria, Victoria, Canada.
Department of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH